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Abstract
Background: Coronary artery disease (CAD) is a leading cause of mortality, morbidity, and
disability with high health care cost in Iran. It accounts for nearly 50 percent of all deaths per year.
Yet little is known about CAD and CAD risk factors in the Iranian population. We aimed to assess
the prevalence of different CAD risk factors in an Iranian population.
Methods: A descriptive cross sectional survey was conducted involving 3000 healthy adults at 18
years of age or above who were recruited with cluster random sampling. Demographic data and
risk factors were determined by taking history, physical examination and laboratory tests.
Results: The average age was 36.23 ± 15.26. There was 1381 female (46%) and 1619 male (54%)
out of which 6.3% were diabetic, 21.6% were smoker, and 15% had positive familial heart disease
history. 61% had total cholesterol level > 200 mg/dL, 32% triglyceride > 200 mg/dl, 47.5% LDL-c >
130 mg/dl, 5.4% HDL-c < 35 mg/dl, 13.7% systolic blood pressure > 140 mmHg, 9.1% diastolic
blood pressure > 90 mmHg and 87% of them were physically inactive.
Conclusion: Clinical and Para-clinical data indicated that Iranian adult population are of a high level
of CAD risk factors, which may require urgent decision making to address national control
measures regarding CAD.
Background
CAD is a leading cause of mortality, morbidity, and disa-
bility in Iranian population. It accounts for nearly 50 per-
cent of all deaths per year. CAD is characterized by the
presence of atherosclerosis in the epicardial coronary
arteries. Atherosclerotic plaques, the hallmark of athero-
sclerosis, progressively narrow the coronary artery lumen
and impair ante grade myocardial blood flow. The reduc-
tion in coronary artery flow may be symptomatic or
asymptomatic, may occur with exertion or at rest, and
may culminate in a myocardial infarction, depending on
obstruction severity and the rapidity of its development
[1]. CAD is the most common form of cardiovascular dis-
ease with an estimated prevalence of CAD in men is 6.9%
and 6% among women [1]. For people at 18 years of age
and above prevalence estimates are: only 11.4 percent
among whites. While 5.9 percents suffered from heart dis-
ease, 5.9 percent have hypertension and 2.3 percent have
had a stroke [2].
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Among African Americans black only, 9.9 percents had
heart disease, 5.3 percents CHD,31.6 percents had hyper-
tension and 3.5 percents had experienced a stroke [2].
Among Hispanics or Latinos, 7.7 percents had heart dis-
ease, 4.5 percents have CHD, 19.0 percents had hyperten-
sion and 2.2 percents had a stroke[2]. Among Asians, 5.6
percents had heart disease, 3.8 percents had CHD, 16.1
percents had hypertension and 1.8 percents a stroke[2]. In
South Asia the prevalence of hypertension is 3.2 percent,
diabetes 2.6 percent, and CAD is 3.2 percent. However, in
Urban and immigrant populations the prevalence rates
are, 12–20 percents, 6–8 percents and, 7–14 percents
respectively. Mean serum cholesterol level is 180–200
mg/dl, frequency of obesity 5–8% and dietary fat intake
contains 20–30% of total calorie intake[3]. Several sub-
groups of South Asia do have high smoking rates, espe-
cially in Urban areas. The prevalence of cigarette smoking
in Indians was 1.3% as compared with 27% in whites in
the UK, cholesterol levels among Indians were found to be
lower than the native population, while in the USA total
cholesterol and LDL-c level among Indians and whites
were similar. In a study of migrant Indians physicians to
the USA, mean level of HDL-c level were significantly less
in younger Indian men and women than their Western
counterparts. Similar trends have been found for triglycer-
ides as well[4]. Among the known risk factors, levels of
HDL-c have been found to be inherently low in the nor-
mal South Asians population. Low HDL-c alone or in
combination with high levels of LDL-c, insulin resistance
and hypertension constitute a very important intermedi-
ate phenotype for CAD. In a recent study on young myo-
cardial infarction patients, 70.3% were found to have
HDL-c lower than 40 mg/dl [5].
The average annual rates for the first major cardiovascular
events rise from seven per 1000 men at 35 – 44 years of
age to 68 per 1000 at 85 – 94 years of age. For women,
comparable rates occur 10 years later in life[6]. Prelimi-
nary mortality data proved CVD as the underlying cause
of death accounting for 37.3 percent of all deaths, or one
of every 2.7, in the United States in 2003. CVD as an
underlying or contributing cause of death accounted for
about 58 percent of the deaths in 2002 [1]. Data from the
2003 BRFSS study of adults of 18 years of age and above
showed the prevalence of respondents reporting two or
more risk factors for heart disease and stroke increased
among successive age groups. The prevalence of having
two or more risk factors was highest among the blacks
(48.7 percents) and American Indians/Alaska Natives
(46.7 percents) and lowest among Asians (25.9 percents),
the prevalence was similar in women (36.4 percents) and
men (37.8 percents) were similar[1]. The estimated direct
and indirect costs for coronary heart disease in 2006 is
$142.5 billion[1].
CAD is a chronic process that begins during adolescence
and slowly progresses throughout life. Independent risk
factors include a family history of premature CAD, ciga-
rette smoking, diabetes mellitus, hypertension, dyslipi-
demia, a sedentary life style, advanced age, gender and
obesity. The risk factors accelerate or modify a complex
and chronic inflammatory process that ultimately mani-
fests as fibrous atherosclerotic plaque [1]. The Incidence
of CAD is compatible with the pattern of the distribution
of CAD risk factors, CAD occurs when its risk factors are
present. According to a case-control study of 52 countries
(INTER HEART), nine easily measured and potentially
modifiable risk factors accounts for over 90 percent of the
risk of an initial acute myocardial infarction (MI). The
effect of these risk factors is consistent in men and
women, across different geographic regions, and by ethnic
group, making the study applicable worldwide. These
nine risk factors include cigarette smoking, abnormal
blood lipid levels, hypertension, diabetes, abdominal
obesity, a lack of physical activity, low daily fruit and veg-
etable consumption, alcohol over consumption, and the
psychosocial index[7].
This study utilized a population based survey to measure
the prevalence of different CAD risk factors in an Iranian
population sample where little is known about CAD, the
disease burden, and risk factors.
Methods
A cross sectional survey was conducted to assess the prev-
alence of different CAD risk factors utilizing the medical
history, physical examination and laboratory tests to con-
sider known risk factors. In a population based survey
among the general population in Tehran, Iran we applied
cluster random sampling and calculated 3000 for the sam-
ple population. We collected the data regarding risk fac-
tors for all healthy individuals (regarding to the public
health school on London questionnaire) of 18 years of
age and above. After completing the informed consent
(verbal consent), all participants were given an interview,
physical examination and blood sample tests. Per proto-
col blood samples were obtained for FBS, total choles-
terol, LDL-c, HDL-c, and triglyceride(TG). FBS were
assayed at the enzymatic methodology by glucose oxidize
Kid. Total cholesterol and TG assayed with enzymatic
methodology and HDL-c level was measured by poly
cat++ precipitating methodology. Study protocol was
approved by ethical committee of the medical faculty.
Statistical analysis
Descriptive analysis was used to process the outcomes in
tables and graphs. Frequency tables was used to describe
the categorical variables, and calculation of the means and
SD was performed to describe the continuous variablesBMC Cardiovascular Disorders 2007, 7:32 http://www.biomedcentral.com/1471-2261/7/32
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Results
The 3000 persons with a mean age and standard deviation
of 36.23 ± (15.26) respectively were analyzed out of
which 46 percent (1381) were female and 54 percent
(1619) were male.
Table 1 demonstrate the prevalence of risk factors under
the study including, diabetes, total cholesterol, triglycer-
ide, LDL-c, HDL-c, systolic and diastolic blood pressures,
family history of CAD, cigarette smoking and physical
inactivity.
Table 2 presents the description of number, mean and
standard deviation of the quantity of the risk factors.
Table 3 shows the prevalence of diabetes, cigarette smok-
ing (CS) and physical inactivity, blood pressure and dysli-
pedemia for the two genders.
Diabetes was more common within the age group of
46–55 years, and in individuals who were inactive (exer-
cise less than 30 minutes, three times a week) in compar-
ison with physically active persons. (82.1% versus 17.9%)
Prevalence of hypertension (blood pressure ≥ 140/90
mmHg) was higher in female than in male, and within
56–65 age group of our sample. Of those who had a sed-
entary life style 82.2% suffered from hypertension among
whom 17.8 percents did exercise.
In this study, physical inactivity was found to be more
common among the females, and the illiterate or persons
with an educational level lower than high school com-
pared with high schoolers and those with a university
degree, (37% versus 63%)
There were 9.9 percents of women who had a history of
oral contraceptive pills (OCP) use and .34.2 percents of
whom had a history of more than ten years of OCP use.
Females more than males were dislipedemic, and the
prevalence of physical inactivity was higher in patients
with dyslipidemia in comparison with those of a normal
level of lipids (75.3% versus 24.7%).
Discussion
CAD is the epidemic of our time and set to remain the sin-
gle most important disease in the world in the terms of
mortality, morbidity, disability and economic loss until
2020 year [8]. This chronic disease has an enormous
impact on quality of life. Its Risk factors accelerate or
modify a complex and chronic inflammatory process that
ultimately manifest as fibrous atherosclerotic plaque [1],
the clinical coronary events follow plaque rupturing. The
presence and the number of CAD risk factors predict the
future cardiovascular events in individuals with such fac-
tors.
In the present study we conducted a population based sur-
vey to assess the prevalence of CAD risk factors, which is
the only study of this nature in Iran, and the results of the
study revealed the high frequency of risk factors in our
sample.
The development of the concept of risk factors and their
relationship to the incidence of CAD evolved from pro-
spective epidemiological studies in the United States and
Europe [9-12]. The identification of risk factors provides a
means for decreasing CAD risks, through the reduction of
modifiable risk factors, and better treatment decisions,
through more accurate determination of overall risk status
[13]. Risk factors reduction is the primary clinical
approach to preventing CAD morbidity and mortal-
ity[14]. Epidemiological studies have clearly demon-
strated that, hypertension, use of tobacco and
dyslipidemia are the major risk factors of CAD which act
in a synergistic manner[14]. With the prevalence of risk
factors for CAD is increasing, and with the clinical and
Table 2: Distribution of some risk factors
Risk factors Total Mean SD
FBS (mg/dL) 3000 113.98 ± 37.02
Total cholesterol (mg/dL) 3000 220.64 ± 55.34
Triglyceride (mg/dl) 3000 196.83 ± 92.29
HDLC (mg/dl) 3000 41.68 ± 13.24
LDLC (mg/dl) 3000 128.15 ± 41.57
F.B.S : Fasting Blood Sugar
LDL-c: Low Density Lipoprotein
HDL-c: High Density Lipoprotein
mg/dl : Milligram per Deciliter
Table 1: Prevalence of CAD risk factors
Risk factors Frequency Total
Diabetes 6.3% (189) 3000
Total cholesterol > 200 mg/dl 61% (1830) 3000
Triglyceride > 200 mg/dl 32% (960) 3000
LDLC > 130 mg/dl 45.5% (1365) 3000
HDLC < 35 mg/dl 5.4% (162) 3000
Systolic blood pressure > 140 mmHg 13.7% (411) 3000
Diastolic blood pressure > 90 mmHg 9.1% (273) 3000
Family history of CAD in first degree 
relatives
15% (450) 3000
Cigarette smoking (active smoker) 21/6% (648) 3000
Sedentary life style 87% (2610) 3000
LDL-c: Low Density Lipoprotein
HDL-c: High Density Lipoprotein
C.A.D : Coronary Artery Disease
mg/dl : Milligram per DeciliterBMC Cardiovascular Disorders 2007, 7:32 http://www.biomedcentral.com/1471-2261/7/32
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cost burdens mounting, identifying and treating those at
risk remains a national priority[15,16].
Comparison of the present study with KANALA in
2002[17] and former research in US and Europe
[7,9,10,14] revealed a similar pattern of the prevalence of
a number of risk factors, so that our population have a
much higher level in such risk factors as, total cholesterol,
LDL-c and physical inactivity. Also in hypertriglyceri-
demia and low HDL-c frequency, we find out a different
pattern [17].
A comparison between our study and that of heart disease
and stroke statistics 2006 up date[1], indicate that the
prevalence of hypercholestrolemia, LDL-c equal than 130
mg/dl or higher and physical inactivity is significantly
higher in our population. This huge difference might be
addressed in the epidemic aspects of CAD arguments[1].
Our results and the above report[1]demonstrate a similar
prevalence of diabetes and cigarette smoking. Low level of
HDL-c level is much more common in the 2006 report of
heart disease and stroke statistics, than that in our popu-
lation[1].
A high prevalence of CAD risk factors, as expected, exist
which is in line with economic development. The pres-
ence of a high level of most risk factors along with the
absence of national and local area control measures in our
population, strongly predicts the epidemic status of CAD
in this population in the next future. The results of this
study may lead to a decision made to address the issue at
a national level. Control programs regarding CAD, via
modifying the modifiable risk factors are envisaged.
According to the current ATP III guidelines, determining
fasting lipid levels together with the presence of clinical
signs and other known risk factors would generate an esti-
mated 10 year risk for CAD. On the basis of this risk
assessment, aggressive life style and treatment guidelines
are recommended [15].
Recent scientific evidence [18-22] together with the joint
AHA/CDC guidelines [15], however, strongly recom-
mends that in performing a global risk assessment for
CAD, new risk factors to measure heart attack risk such as
circulating markers of inflammation like C-reactive pro-
tein (CRP)should be used. Such augmentation provides
the best method of determining the global risk assessment
for CAD.
For primary prevention purposes individuals with docu-
mented risk factors should actively pursue risk factor
modifications to reduce the risk of future cardiovascular
events. Life style modifications with guidance and strong
encouragement of the physician-led health care team, can
make a significant positive impact on the future cardiovas-
cular and vascular event rates.
Conclusion
According to the prevalence of risk factors, which 6.3% of
the study population were diabetic, 21.6% were smoker,
and 15% had a positive familial heart disease.61% had
total cholesterol level > 200 mg/dl, 32% triglyceride > 200
mg/dl, 47.5% LDL-c > 130 mg/dl, 5.4% HDL-c < 35 mg/
dl, 13.7% systolic blood pressure > 140 mmHg, 9.1%
diastolic blood pressure > 90 mmHg and 87% of them
were physically inactive. The researchers strongly recom-
mend whole population strategy of primary prevention of
the cad to be designed and practiced. Managing this bur-
den of risk factors can prevent the following cardiovascu-
lar event rates, and should assist managing the future
CAD.
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Table 3: Prevalence of risk factors in female and male
Gender/ Risk factors  Diabetes CS Physical Inactivity Systolic BP > 140 
mmHg
Dyslipedemia
Female 3.21% (97) 2.5% (85) 48% (1440) 7.8% (234) 34% (1020)
Male 2.09% (93) 18.9% (599) 39% (1170) 5.9% (177) 26% (780)
Total 6.3% (190) 21.6% (684) 87% (2610) 13.7% (411) 60% (1800)
CS: Cigarette Smoking
BP : Blood Pressure
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